We collaborate with industry pioneers and innovators to transform genomic insights into actionable discoveries
Target discovery and pipeline innovation
Genomics combines world-leading data with advanced analytics, integrating genetics, biology and AI/ML to revolutionise drug development. We enable identification of novel targets and support genetic-driven asset repurposing for new disease applications. Accelerate your pipeline by translating causal biology insights into high-value decisions for optimised drug development.
Genomics-based patient stratification
Our advanced methods reveal disease heterogeneity at the molecular level, enabling precise population characterisation from target discovery through clinical implementation. By stratifying patients using multimodal data, we help de-risk clinical trials through targeted selection, discover novel biomarkers, and develop prognostic tools for personalised therapeutic decisions.
Advancing Precision Medicine
Genomics-based approaches to understanding disease pathophysiology enable the realisation of precision medicine, where therapeutic intervention can be tailored to patient subpopulations based on disease burden, likely disease trajectory, or therapeutic response. Genomics’ technology for patient stratification powers the identification and treatment of patient subgroups, enhancing the matching of patients to the best potential therapeutic at the right time.
Accelerate your research with genomic insights
Discover how our advanced genomic analysis can transform your drug discovery and development pipeline. Schedule a consultation with our team to learn more.
Contact us
